Navi Medical raises A$6.8 million to commercialize Neonav in the United States

The medical device company said the funding follows FDA 510(k) clearance, expanded 2026 indications and early clinical evaluations at two U.S. children's hospitals.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.